GLP1ProviderCompare
NexLife $215Yucca Health $258IVIM Health $278Mochi Health $278Found $289ShedRx $289OrderlyMeds $299SkinnyRx $299Amble Health $300Oak Longevity $133 semaYucca Health $146 semaOrderlyMeds $149 semaNexLife $165 semaall-in monthly · verified 2026-08-05 · databaseNexLife $215Yucca Health $258IVIM Health $278Mochi Health $278Found $289ShedRx $289OrderlyMeds $299SkinnyRx $299Amble Health $300Oak Longevity $133 semaYucca Health $146 semaOrderlyMeds $149 semaNexLife $165 semaall-in monthly · verified 2026-08-05 · database

Provider review · verified None

MyStart Health review: pricing, fine print, and how it ranks

tracked; no published price we could verify — verified None, third-party-reported.

Third-party-reported
Tirzepatide (reported, unverified)
$179/mo — third-party figure; excluded from rankings
Semaglutide (reported, unverified)
$179/mo — third-party figure; excluded from rankings
Tirzepatide, all-in at 10 mg
Offered — no published price
Semaglutide, all-in
Offered — no published price
Membership fee
None
Price evidence
Third-party-reported

The price, in words

MyStart Health is reported at tirzepatide at $179/mo and semaglutide at $179/mo — figures published by a competing comparison site (May 2026), not read on a provider pricing page we could capture. We list reported figures for completeness and exclude them from every ranking until source verification; our methodology treats an unverifiable low price as a question, not a winner.

What the fine print says

MyStart's $179 both-molecule figure and compounded-to-brand 'upgrade path' come from a competing site's May 2026 roundup; we could not verify either on a provider page at capture. Unranked pending verification.

Pharmacy & transparency

Price evidence: Third-party-reported. The dispensing pharmacy is not named publicly — the single most common transparency gap in this market. Ask which pharmacy fills the prescription, whether it is 503A or 503B, and whether a certificate of analysis is available; our pharmacy guide explains what each answer means.

Nearest alternatives at this price point

Shopping the immediate neighborhood, the closest verified substitutes are NexLife at $215 (flat at every dose, no membership, named pharmacy); Yucca Health at $258 (flat at every dose, no membership, prepaid to $225); IVIM Health at $278 (source-verified) — each linked matchup runs the full head-to-head arithmetic on this exact question.

State availability

MyStart Health doesn't publish a state footprint we could capture — confirm your state at intake before anything else. State-by-state context, exceptions, and city coverage live in the 51-state cost guides.

Five questions before checkout

Whatever the marketing says, get answers to: (1) the current all-in monthly price, in writing, since no verifiable figure is published; (2) whether the price changes at any rung of the dose ladder, and the exact tier schedule; (3) which pharmacy, by name, fills the prescription — and whether it's 503A or 503B, licensed for your state, with a certificate of analysis available; (4) the cancellation mechanics — deadline relative to renewal, written-confirmation availability, and whether any membership cancels separately. A program that answers all five plainly has already told you most of what this review can.

Bottom line

Until MyStart Health publishes verifiable pricing, treat any quoted figure as unconfirmed and get it in writing. For context, the verified market floor is $215/mo compounded tirzepatide and $133/mo compounded semaglutide, with brand Zepbound at $449/mo and Wegovy at $349/mo at maintenance.

MyStart Health: quick answers

How much does MyStart Health cost?

MyStart Health publishes no medication price we could verify; we track it as unpriced. Request current pricing in writing before enrolling.

Does MyStart Health charge a membership fee?

No separate membership fee; the monthly price is the billed total (before any add-ons you choose).

Is MyStart Health legit?

MyStart Health is a real, operating program we track. It sells compounded GLP-1s, which are not FDA-approved and operate under the contested post-shortage pathways described in our legal guide. It does not publicly name its dispensing pharmacy — ask before you buy.